Qiang Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qiang Lu has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Cailan Li
Department of Pharmacology, Zunyi Medical University, Zhuhai Campus, Zhuhai 519041, PR China
8 shared publications Cailan Li
Department of Pharmacology, Zunyi Medical University, Zhuhai Campus, Zhuhai 519041, PR China; Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, PR China; Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, PR China
6 shared publicationsHaohui Chen
Department of Pharmaceutical Sciences, Zunyi Medical University, Zhuhai Campus, Zhuhai, 519041, China
4 shared publicationsJianhui Xie
Department of Pharmacology, Zunyi Medical University, Zhuhai Campus, Zhuhai, China
3 shared publicationsJingjing Wu
Department of Pharmaceutical Sciences, Zunyi Medical University, Zhuhai Campus, Zhuhai, 519041, China
3 shared publicationsLuyou Zhao
Department of Pharmaceutical Sciences, Zunyi Medical University, Zhuhai Campus, Zhuhai, 519041, China
3 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by MDPI AG in Marine Drugs
- Vol. 24  (10) , 332
Marine-Derived Polysaccharides Against Ulcerative Colitis: Sources, Structures, and Multi-Target Mechanisms
Marine-derived polysaccharides have emerged as promising bioactive candidates for alleviating ulcerative colitis (UC), a chronic inflammatory bowel disease with limited therapeutic options. This review systematically summarizes recent advances in the sources, preparation methods, structural features, and multi-target mechanisms of these polysaccharides from seaweeds, marine animals, and microorganisms. Key physicochemical parameters, including molecular weight, monosaccharide composition, glycosidic linkages, and sulfation patterns, critically influence their anti-colitis efficacy. Mechanistically, these macromolecules synergistically restore gut microbiota homeostasis (e.g., promoting short-chain fatty acids and secondary bile acids), suppress inflammatory pathways (NF-κB, MAPK, and NLRP3), regulate immune responses (inhibiting dendritic cell and Th1/Th17 activation), alleviate oxidative stress via the Nrf2/HO-1 pathway, and reinforce intestinal epithelial barrier integrity (upregulating tight junction proteins and mucins). Although systematic toxicological characterization remains limited, the generally favorable safety profiles reported in preclinical studies, together with their multi-target nature, suggest that marine polysaccharides hold great potential as functional foods or adjunctive therapies for UC. However, challenges remain in structural heterogeneity, batch-to-batch consistency, and limited clinical validation. Future efforts should prioritize structure–activity relationship elucidation, advanced analytical characterization, bioavailability and gastrointestinal fate studies, standardization and quality control, comparative evaluation against conventional therapies and other natural products, and well-designed clinical trials to facilitate translation from bench to bedside.
- 23 September 2026
- Published by MDPI AG in Marine Drugs
- Vol. 24  (10) , 332
Open AccessMarine-Derived Polysaccharides Against Ulcerative Colitis: Sources, Structures, and Multi-Target Mechanisms
Marine-derived polysaccharides have emerged as promising bioactive candidates for alleviating ulcerative colitis (UC), a chronic inflammatory bowel disease with limited therapeutic options. This review systematically summarizes recent advances in the sources, preparation methods, structural features, and multi-target mechanisms of these polysaccharides from seaweeds, marine animals, and microorganisms. Key physicochemical parameters, including molecular weight, monosaccharide composition, glycosidic linkages, and sulfation patterns, critically influence their anti-colitis efficacy. Mechanistically, these macromolecules synergistically restore gut microbiota homeostasis (e.g., promoting short-chain fatty acids and secondary bile acids), suppress inflammatory pathways (NF-κB, MAPK, and NLRP3), regulate immune responses (inhibiting dendritic cell and Th1/Th17 activation), alleviate oxidative stress via the Nrf2/HO-1 pathway, and reinforce intestinal epithelial barrier integrity (upregulating tight junction proteins and mucins). Although systematic toxicological characterization remains limited, the generally favorable safety profiles reported in preclinical studies, together with their multi-target nature, suggest that marine polysaccharides hold great potential as functional foods or adjunctive therapies for UC. However, challenges remain in structural heterogeneity, batch-to-batch consistency, and limited clinical validation. Future efforts should prioritize structure–activity relationship elucidation, advanced analytical characterization, bioavailability and gastrointestinal fate studies, standardization and quality control, comparative evaluation against conventional therapies and other natural products, and well-designed clinical trials to facilitate translation from bench to bedside.
- Open Access
- 6 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16  (26) , 23637-23650
Oleuropein derived from olive leaves inhibits the activity of Helicobacter pylori urease: network pharmacology, inhibition kinetics, and mechanistic insights
Oleuropein inhibited the activity of H. pylori urease in a time-dependent, mixed-type and reversible manner. Mechanistic analyses suggested that the inhibition was associated with thiol groups on urease and may involve the flap residue CYS321.
- 6 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16  (26) , 23637-23650
Open AccessOleuropein derived from olive leaves inhibits the activity of Helicobacter pylori urease: network pharmacology, inhibition kinetics, and mechanistic insights
Oleuropein inhibited the activity of H. pylori urease in a time-dependent, mixed-type and reversible manner. Mechanistic analyses suggested that the inhibition was associated with thiol groups on urease and may involve the flap residue CYS321.
- 20 April 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
Therapeutic Promise of the Panax Genus in Ulcerative Colitis: Unraveling the Multitarget Mechanisms of Saponins and Polysaccharides
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a rising global incidence. Panax genus plants, recognized for their anti-inflammatory and immunomodulatory properties, present as a promising therapeutic candidate. This review summarizes the last few decades of research on Panax species, including Panax ginseng, Panax notoginseng, Panax quinquefolius, Panax japonicus, and Panax vietnamensis, for UC management. Therapeutic efficacy is primarily attributed to saponins (e.g., ginsenosides) and polysaccharides, which operate through distinct yet complementary pathways. Advancing beyond traditional single-species investigations, this work adopts a novel genus-wide perspective to elucidate functional synergy between bioactive families. Saponins exert precise immunomodulatory actions by inhibiting intracellular signaling cascades, including NF-κB, MAPK, and NLRP3 pathways, and modulating T-cell differentiation. Conversely, polysaccharides primarily orchestrate intestinal homeostasis at the epithelial interface by reinforcing barrier integrity and regulating microbial ecology. This comparative analysis identifies species-specific therapeutic advantages, establishing a strategic framework for sustainable resource utilization and precision drug development in UC therapy.
- 20 April 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
Therapeutic Promise of the Panax Genus in Ulcerative Colitis: Unraveling the Multitarget Mechanisms of Saponins and Polysaccharides
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a rising global incidence. Panax genus plants, recognized for their anti-inflammatory and immunomodulatory properties, present as a promising therapeutic candidate. This review summarizes the last few decades of research on Panax species, including Panax ginseng, Panax notoginseng, Panax quinquefolius, Panax japonicus, and Panax vietnamensis, for UC management. Therapeutic efficacy is primarily attributed to saponins (e.g., ginsenosides) and polysaccharides, which operate through distinct yet complementary pathways. Advancing beyond traditional single-species investigations, this work adopts a novel genus-wide perspective to elucidate functional synergy between bioactive families. Saponins exert precise immunomodulatory actions by inhibiting intracellular signaling cascades, including NF-κB, MAPK, and NLRP3 pathways, and modulating T-cell differentiation. Conversely, polysaccharides primarily orchestrate intestinal homeostasis at the epithelial interface by reinforcing barrier integrity and regulating microbial ecology. This comparative analysis identifies species-specific therapeutic advantages, establishing a strategic framework for sustainable resource utilization and precision drug development in UC therapy.
- Open Access
- 21 March 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24
Biogenesis, preparation, characterization, therapeutic mechanisms and safety evaluation of plant-derived exosome-like nanovesicles in the treatment of ulcerative colitis
Ulcerative colitis remains a challenging clinical condition due to its complex etiology and the limitations of current therapies. Plant-derived exosome-like nanovesicles (PDELNs) represent a new class of natural nanotherapeutics with significant potential for ulcerative colitis treatment. These nanoparticles exhibit high biocompatibility, the ability to cross biological barriers, and carry a rich cargo of bioactive molecules. This review synthesizes progress in PDELN research over the past decade, focusing on established preparation methods and their multi-targeted therapeutic mechanisms. The current isolation methods of the anti-colitis PDELNs are mainly various types of centrifugation, including ultracentrifugation, differential centrifugation, density gradient centrifugation and their combination. Therapeutically, PDELNs alleviate colitis through potent anti-inflammatory effects, gut microbiota remodeling, and immune response regulation. These effects are attributed to key bioactive components such as plant microRNAs, metabolites, and lipids. Notably, PDELNs demonstrate an excellent safety profile without reported toxicity. Their natural origin, multi-targeted mechanisms, and favorable biosafety profile make PDELNs a promising next-generation therapeutic candidate against colitis, effectively bridging traditional phytotherapy and modern nanomedicine. Graphical Abstract
- 21 March 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24
Open AccessBiogenesis, preparation, characterization, therapeutic mechanisms and safety evaluation of plant-derived exosome-like nanovesicles in the treatment of ulcerative colitis
Ulcerative colitis remains a challenging clinical condition due to its complex etiology and the limitations of current therapies. Plant-derived exosome-like nanovesicles (PDELNs) represent a new class of natural nanotherapeutics with significant potential for ulcerative colitis treatment. These nanoparticles exhibit high biocompatibility, the ability to cross biological barriers, and carry a rich cargo of bioactive molecules. This review synthesizes progress in PDELN research over the past decade, focusing on established preparation methods and their multi-targeted therapeutic mechanisms. The current isolation methods of the anti-colitis PDELNs are mainly various types of centrifugation, including ultracentrifugation, differential centrifugation, density gradient centrifugation and their combination. Therapeutically, PDELNs alleviate colitis through potent anti-inflammatory effects, gut microbiota remodeling, and immune response regulation. These effects are attributed to key bioactive components such as plant microRNAs, metabolites, and lipids. Notably, PDELNs demonstrate an excellent safety profile without reported toxicity. Their natural origin, multi-targeted mechanisms, and favorable biosafety profile make PDELNs a promising next-generation therapeutic candidate against colitis, effectively bridging traditional phytotherapy and modern nanomedicine. Graphical Abstract
- 30 January 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 363, 121301
Nitidine chloride alleviates inflammation and pyroptosis by inhibiting the NLRP3/Caspase-1/GSDMD signaling pathway in macrophages and murine models
- 30 January 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 363, 121301
Nitidine chloride alleviates inflammation and pyroptosis by inhibiting the NLRP3/Caspase-1/GSDMD signaling pathway in macrophages and murine models
- 23 October 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 167, 115697
Coptisine alleviates intestinal barrier dysfunction and inflammation in TNBS-induced colitis rats and LPS-stimulated human intestinal Caco-2 cells
- 23 October 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 167, 115697
Coptisine alleviates intestinal barrier dysfunction and inflammation in TNBS-induced colitis rats and LPS-stimulated human intestinal Caco-2 cells
- 8 August 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 335, 118680
Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome
- 8 August 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 335, 118680
Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome
- Open Access
- 3 March 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1120616
Potential of natural flavonols and flavanones in the treatment of ulcerative colitis
Ulcerative colitis (UC) is an inflammatory bowel disease generally characterized by chronic, persistent, recurrent, and non-specific ulcers of the intestine. Its main clinical manifestations include abdominal pain, diarrhea, and bloody stools. This disease is difficult to cure and even carries the risk of canceration. It has been listed as a modern refractory disease by the World Health Organization. Though a large amount of drugs are available for the inhibition of UC, the conventional treatment such as aminosalicylic acids, glucocorticoids, immunosuppressors, and biological agents possess certain limitations and serious side effects. Therefore, it is urgently needed for safe and effective drugs of UC, and natural-derived flavonols and flavanones showed tremendous potential. The present study concentrated on the progress of natural-derived flavonols and flavanones from edible and pharmaceutical plants for the remedy of UC over the last two decades. The potential pharmaceutical of natural-derived flavonols and flavanones against UC were closely connected with the modulation of gut microflora, gut barrier function, inflammatory reactions, oxidative stress, and apoptosis. The excellent efficacy and safety of natural flavonols and flavanones make them prospective drug candidates for UC suppression.
- 3 March 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1120616
Open AccessPotential of natural flavonols and flavanones in the treatment of ulcerative colitis
Ulcerative colitis (UC) is an inflammatory bowel disease generally characterized by chronic, persistent, recurrent, and non-specific ulcers of the intestine. Its main clinical manifestations include abdominal pain, diarrhea, and bloody stools. This disease is difficult to cure and even carries the risk of canceration. It has been listed as a modern refractory disease by the World Health Organization. Though a large amount of drugs are available for the inhibition of UC, the conventional treatment such as aminosalicylic acids, glucocorticoids, immunosuppressors, and biological agents possess certain limitations and serious side effects. Therefore, it is urgently needed for safe and effective drugs of UC, and natural-derived flavonols and flavanones showed tremendous potential. The present study concentrated on the progress of natural-derived flavonols and flavanones from edible and pharmaceutical plants for the remedy of UC over the last two decades. The potential pharmaceutical of natural-derived flavonols and flavanones against UC were closely connected with the modulation of gut microflora, gut barrier function, inflammatory reactions, oxidative stress, and apoptosis. The excellent efficacy and safety of natural flavonols and flavanones make them prospective drug candidates for UC suppression.
- Open Access
- 21 September 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 969550
Therapeutic effects and mechanisms of plant-derived natural compounds against intestinal mucositis
Intestinal mucositis is a clinically related adverse reaction of antitumor treatment. Majority of patients receiving high-dose chemical therapy, radiotherapy, and bone-marrow transplant suffer from intestinal mucositis. Clinical manifestations of intestinal mucositis mainly include pain, body-weight reduction, inflammatory symptom, diarrhea, hemoproctia, and infection, which all affect regular nutritional input and enteric function. Intestinal mucositis often influences adherence to antitumor treatment because it frequently restricts the sufferer’s capacity to tolerate treatment, thus resulting in schedule delay, interruption, or premature suspension. In certain circumstances, partial and general secondary infections are found, increasing the expenditures on medical care and hospitalization. Current methods of treating intestinal mucositis are provided, which do not always counteract this disorder. Against this background, novel therapeutical measures are extremely required to prevent and treat intestinal mucositis. Plant-derived natural compounds have lately become potential candidates against enteric injury ascribed to the capacity to facilitate mucosal healing and anti-inflammatory effects. These roles are associated with the improvement of intestinal mucosal barrier, suppression of inflammatory response and oxidant stress, and modulation of gut microflora and immune system. The present article aims at systematically discussing the recent progress of plant-derived natural compounds as promising treatments for intestinal mucositis.
- 21 September 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 969550
Open AccessTherapeutic effects and mechanisms of plant-derived natural compounds against intestinal mucositis
Intestinal mucositis is a clinically related adverse reaction of antitumor treatment. Majority of patients receiving high-dose chemical therapy, radiotherapy, and bone-marrow transplant suffer from intestinal mucositis. Clinical manifestations of intestinal mucositis mainly include pain, body-weight reduction, inflammatory symptom, diarrhea, hemoproctia, and infection, which all affect regular nutritional input and enteric function. Intestinal mucositis often influences adherence to antitumor treatment because it frequently restricts the sufferer’s capacity to tolerate treatment, thus resulting in schedule delay, interruption, or premature suspension. In certain circumstances, partial and general secondary infections are found, increasing the expenditures on medical care and hospitalization. Current methods of treating intestinal mucositis are provided, which do not always counteract this disorder. Against this background, novel therapeutical measures are extremely required to prevent and treat intestinal mucositis. Plant-derived natural compounds have lately become potential candidates against enteric injury ascribed to the capacity to facilitate mucosal healing and anti-inflammatory effects. These roles are associated with the improvement of intestinal mucosal barrier, suppression of inflammatory response and oxidant stress, and modulation of gut microflora and immune system. The present article aims at systematically discussing the recent progress of plant-derived natural compounds as promising treatments for intestinal mucositis.
- 1 January 2022
- Published by Elsevier in Pharmacological Research
- Vol. 175, 105972
Natural-derived alkaloids exhibit great potential in the treatment of ulcerative colitis
- 1 January 2022
- Published by Elsevier in Pharmacological Research
- Vol. 175, 105972
Natural-derived alkaloids exhibit great potential in the treatment of ulcerative colitis